LiveLoadingtotal visitors

Open source
Global perspectives

Global diabetes: count, prevalence, and access

Read WHO estimates with clear denominators and dates, and distinguish the growing population burden from incidence and mortality.

2 min readEasy read1 sourcesChecked 30 Sept 2026Established

By The Diabetes Guide editorial project · Updated 30 Sept 2026

On this page
In simple words

The WHO estimates about 830 million people had diabetes in 2022, up from about 200 million in 1990. Access to treatment differs greatly between countries.

  1. Step 1: Three different numbers

    Count is how many people, prevalence is the share of people, incidence is new cases over time.

    For example: How many students, what share of the school, how many joined this year.

  2. Step 2: The WHO estimates

    Adult prevalence rose from about 7% to about 14% between 1990 and 2022.

    For example: The share of the class with glasses doubled.

  3. Step 3: Access matters

    Treatment gaps are large in lower-income places.

    For example: Having a medicine on paper does not help if you cannot get it.

Remember: Count, prevalence and incidence are different measures.

The full story

Want more? Below is the detailed version with the real science words. It is fine to skip it.

Different metrics answer different questions

Count is the number of people living with diabetes. Prevalence is the proportion of a population living with it. Incidence counts new cases over time. Mortality counts deaths, with attribution methods that differ. They cannot be placed on one unlabeled axis.

The WHO estimates

WHO's November 2024 fact sheet reports about 200 million people living with diabetes in 1990 and 830 million in 2022. Adult prevalence rose from about 7% to 14%. These are estimates for those observation years, not 2026 measurements. 1

Real data · %

Global adult diabetes prevalence

Percentage of adults aged 18 and older living with diabetes

Global adult diabetes prevalence: 1990, 7%; 2022, 14%03.87.511.3157%199014%2022
Who was counted: Adults aged ≥18 globally. WHO estimates for two observation years. The connecting line shows endpoint change, not measured intervening annual values. Not incidence. Source: World Health Organization (2024)

Access shapes outcomes

WHO reports large treatment gaps, especially in lower-income settings. Population aging, urbanization and food environments interact with clinical access. Diabetes burden includes health loss, household costs, care demands and lost productivity; this library does not invent a global cost estimate or regional data series.

Reading future updates

Check age ranges, diagnostic definitions, survey year and model methods before comparing WHO with other organizations. A larger number can reflect a different denominator rather than a sudden rise in disease.

Trace the evidence

Sources and further reading

1.Diabetes — WHO fact sheet (opens in a new tab)

World Health Organization · 2024 · Population study

Strong Evidence
Who was studied, limits and source check

Population: Global population; adult prevalence estimates

Limitations: Modeled estimates for 1990 and 2022; count, prevalence, incidence, and deaths are distinct measures.

Source checked 2026-09-30. See the original publication for full methods.

Source checking is an editorial literature check, not independent medical review. This page is for learning. It cannot diagnose you or make a treatment plan. Evidence labels describe the cited claims, not the whole topic.

What does “Established” mean?

Doctors and scientists agree. This is well known. Like “the sun rises in the east”.

Keep reading

The body

The one-page mental model

Diabetes means there is too much sugar in the blood for too long, because the body does not have enough insulin or cannot use it well.

4 minEasy read

Type 1

Type 1 diabetes: the complete journey

Type 1 diabetes is usually an autoimmune condition. The body’s defence system harms the beta cells, so less and less insulin is made.

4 minEasy read